Description:

ARMN is the ticker symbol for Armata Pharmaceuticals Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on the development and commercialization of novel therapies to address unmet medical needs in the fields of antibiotic-resistant infections and serious lung diseases. Armata's pipeline includes bacteriophage-based therapies and stem cell technologies aimed at treating patients with difficult-to-treat bacterial infections and pulmonary disorders. Investors interested in companies at the forefront of innovative healthcare solutions may find ARMN an intriguing prospect due to its unique approach to addressing critical health issues.

Data:

Yields: